USA – FDA updates GUDID final guidance

The US Food and Drug Administration (FDA) issued an updated final guidance on Tuesday addressing the submission of unique device identifiers (UDIs) to the...
Statement on the Investigational Use of Marketed Drugs in Clinical Trials

Canada – Guidance on terms and conditions for class II to IV medical devices

The Food and Drugs Act (FDA) and its regulations give Health Canada the authority to regulate food, drugs (including natural health products), medical devices and cosmetics....

Europe – MDCG 2022-3 rev.1 – Verification of manufactured class D IVDs by notified...

Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR) establishes the requirements for notified bodies involved in the conformity assessment of applicable classes of...
Statement on the Investigational Use of Marketed Drugs in Clinical Trials

Canada – Drug and medical device databases

This list of Health Canada's drug and medical device databases briefly describes the information available in each database. It does not provide an in...
Trois nouvelles guidances du MDCG en Mars 2020

Europe – MDCG 2019-13 Guidance on sampling of MDR Class IIa / Class...

Regulation (EU) 2017/745 on medical devices (MDR) and Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR) establish the requirements for sampling of...
Practical guidance for procedures related to Brexit for medicinal products for human and veterinary use within the framework of the centralised procedure

Europe – Interface between the Regulations on clinical trials of medicinal products, medical devices...

In the EU, there are legal requirements for the individual authorisation processes of clinical trials of medicinal products, clinical investigations of medical devices and...
Practical guidance for procedures related to Brexit for medicinal products for human and veterinary use within the framework of the centralised procedure

Europe – Commission launches a public consultation and a call for evidence for EU...

The Commission has launched a public consultation and a call for evidence on the EU’s legislation on medical devices and in vitro diagnostic medical devices, as...
MHRA Offers Grace Period for Device Manufacturers Dealing With Withdrawn Notified Bodies

UK – Medical Devices Regulatory Reform – Roadmap to implementation – Update

A roadmap outlining the intended timelines for delivering a future regulatory framework for medical devices and an intended policy on international recognition...

Europe – MDCG 2024-16: Manufacturer Information Form on Interruption or Discontinuation of Supply of...

The Medical Device Coordination Group (MDCG) has introduced new guidance under MDCG 2024-16, streamlining how manufacturers report interruptions or discontinuations in the supply of...

USA – Final FDA guidance on PCCP includes clarification on version control

The US Food and Drug Administration (FDA) has finalized a long-anticipated guidance on using predetermined change control plans (PCCPs) in submissions for medical devices...

NOS PROCHAINES FORMATIONS